Archive by Tag: clinical studies

Social Media and Key Opinion Leaders

Industry Insights from Paul Meade, M.Sc., MPH Social Media has to be the top buzzword of this still-young millennium, and everyone has been jumping on the bandwagon in the last several years (over one-sixth of planet Earth’s population!). We’re way[...]

The Sunshine Act–How Bad Can It Get?

Industry Insights from Paul Meade, M. Sc, MPH For every transaction over ten dollars paid to a physician by a pharmaceutical manufacturer, the Physician Payments Sunshine Provision demands disclosure to a database that will be made public in 2013. Notwithstanding[...]

The Sunshine Act: The Good, the Bad, and the Ugly

Industry Insights from Paul Meade, M. Sc, MPH The Sunshine Act is on the horizon, and all we know for certain is that things will be different. Will the changes be good, bad, or ugly for healthcare and the biopharmaceutical[...]

Clinical Trials—The New Way Forward

Industry Insights from Paul Meade, M. Sc, MPH A recent article in the Wall Street Journal announced that Pfizer is conducting a clinical trial in which patients are able to use their computers and smartphones to enter information about the[...]

Should Doctors Be Paid By Drug Companies?

Industry Insights from Paul Meade, M.Sc., MPH Should doctors be paid by drug companies? Well, I guess that depends on the reason for the payment. If a physician, known for her expertise in a given area, is asked by a[...]

Thought Leader Select Begins Oncology Thought Leader Assessment in Canada

March 16, 2011 (CHAPEL HILL, NC)—Research Triangle, NC research and consulting firm Thought Leader Select has initiated a new assessment of medical experts in the field of oncology for the biopharmaceutical industry. A Canadian subsidiary of a top 10 global[...]

Thought Leader Select Launches Key Opinion Leader Assessment in Mexico

Press Release Out Today from the Offices of Thought Leader Select July 22, 2010 (CHAPEL HILL, NC)—Thought Leader Select, a North Carolina company dedicated to delivering sophisticated key opinion leader research solutions to the biopharmaceutical industry, announces new key opinion[...]

When Real-Time Is a Waste of Time (and Money)!

Industry Insights from Paul Meade, M. Sc, MPH In this Age of Information, many people believe that having up-to-date information at their fingertips is beneficial to managing their businesses. This can’t be truer if you have to make up-to-date decisions[...]